Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Alignment Healthcare, Inc.

Alignment Healthcare, Inc.

ALHC

0.00

Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ: ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.